Skip to main content
. 2022 Mar 15;24(3):299–306. doi: 10.1038/s41556-022-00852-9

Extended Data Fig. 7. Effects of PUS7 depletion and mTOG-Ψ treatment on tRNA levels in MDS-L and HR-MDS cells.

Extended Data Fig. 7

a, Northern blot analysis shows no differences in the levels of precursor and mature tRNA-Tyr (GUA) in PUS7-KD MDS-L ± mTOG-Ψ (left) and CD34- MNC from two aged-matched HC and HR-MDS patients (bottom right). U6 RNA is included as a loading control. Data represent n=3 independent experiments for MDS-L, except when n=1 due to limited patient material availability. b, Representative FACS analysis shows increase immature MDS propagating cells (CD34+/CD45RA+/CD123+) in PUS7-KD MDS-L compared to controls. Graph shows % of CD34+/CD45RA+/CD123+ cells in CTRL and PUS7-KD MDS-L lines. n=5 independent biological replicates, ****p<0.0001 (two-sided t test). Data is shown as mean ± SD.

Source data